PT - JOURNAL ARTICLE AU - Julie K. Staley AU - Deborah C. Mash TI - Adaptive Increase in D<sub>3</sub> Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities AID - 10.1523/JNEUROSCI.16-19-06100.1996 DP - 1996 Oct 01 TA - The Journal of Neuroscience PG - 6100--6106 VI - 16 IP - 19 4099 - http://www.jneurosci.org/content/16/19/6100.short 4100 - http://www.jneurosci.org/content/16/19/6100.full SO - J. Neurosci.1996 Oct 01; 16 AB - The mesolimbic dopaminergic system plays a primary role in mediating the euphoric and rewarding effects of most abused drugs. Chronic cocaine use is associated with an increase in dopamine neurotransmission resulting from the blockade of dopamine uptake and is mediated by the activation of dopamine receptors. Recent studies have suggested that the D3 receptor subtype plays a pivotal role in the reinforcing effects of cocaine. The D3receptor-preferring agonist 7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) is a reinforcer in rhesus monkeys trained to self-administer cocaine, but not in cocaine-naive monkeys. In vitro autoradiographic localization of [3H]-(+)-7-OH-DPAT binding in the human brain demonstrated that D3 receptors were prevalent and highly localized over the ventromedial sectors of the striatum. Pharmacological characterization of [3H]-(+)-7-OH-DPAT binding to the human nucleus accumbens demonstrated a rank order of potency similar to that observed for binding to the cloned D3 receptor expressed in transfected cell lines. Region-of-interest analysis of [3H]-(+)-7-OH-DPAT binding to the D3 receptor demonstrated a one- to threefold elevation in the number of binding sites over particular sectors of the striatum and substantia nigra in cocaine overdose victims as compared with age-matched and drug-free control subjects. The elevated number of [3H]-(+)-7-OH-DPAT binding sites demonstrates that adaptive changes in the D3 receptor in the reward circuitry of the brain are associated with chronic cocaine abuse. These results suggest that the D3 receptor may be a useful target for drug development of anti-cocaine medications.